These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11176659)

  • 1. A trial of oolong tea in the management of recalcitrant atopic dermatitis.
    Uehara M; Sugiura H; Sakurai K
    Arch Dermatol; 2001 Jan; 137(1):42-3. PubMed ID: 11176659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safe and effective treatment of refractory facial lesions in atopic dermatitis using topical tacrolimus following corticosteroid discontinuation.
    Kawakami T; Soma Y; Morita E; Koro O; Yamamoto S; Nakamura K; Tamaki K; Yajima K; Imaizumi A; Matsunaga R; Murakami N; Kashima M; Mizoguchi M
    Dermatology; 2001; 203(1):32-7. PubMed ID: 11549797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of facial atopic dermatitis in children who are intolerant of, or dependent on, topical corticosteroids: a randomized, controlled clinical trial.
    Hoeger PH; Lee KH; Jautova J; Wohlrab J; Guettner A; Mizutani G; Hultsch T
    Br J Dermatol; 2009 Feb; 160(2):415-22. PubMed ID: 19067708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term efficacy of tacrolimus ointment for recalcitrant facial erythema resistant to topical corticosteroids in adult patients with atopic dermatitis.
    Sugiura H; Uehara M; Hoshino N; Yamaji A
    Arch Dermatol; 2000 Aug; 136(8):1062-3. PubMed ID: 10926750
    [No Abstract]   [Full Text] [Related]  

  • 5. Superiority of tacrolimus 0.1% ointment compared with fluticasone 0.005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double-blind trial.
    Doss N; Reitamo S; Dubertret L; Fekete GL; Kamoun MR; Lahfa M; Ortonne JP
    Br J Dermatol; 2009 Aug; 161(2):427-34. PubMed ID: 19416227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Black tea dressings - a rapidly effective treatment for facial dermatitis.
    Witte M; Krause L; Zillikens D; Shimanovich I
    J Dermatolog Treat; 2019 Dec; 30(8):785-789. PubMed ID: 30668184
    [No Abstract]   [Full Text] [Related]  

  • 7. A new topical treatment of atopic dermatitis in pediatric patients based on Ficus carica L. (Fig): A randomized, placebo-controlled clinical trial.
    Abbasi S; Kamalinejad M; Babaie D; Shams S; Sadr Z; Gheysari M; Askari VR; Rakhshandeh H
    Complement Ther Med; 2017 Dec; 35():85-91. PubMed ID: 29154073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group.
    Reitamo S; Wollenberg A; Schöpf E; Perrot JL; Marks R; Ruzicka T; Christophers E; Kapp A; Lahfa M; Rubins A; Jablonska S; Rustin M
    Arch Dermatol; 2000 Aug; 136(8):999-1006. PubMed ID: 10926735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An open study of a lotion formulation to improve tolerance of tacrolimus in facial atopic dermatitis.
    Sugiura H; Uehara M; Hoshino N; Yamaji A
    Br J Dermatol; 2001 Nov; 145(5):795-8. PubMed ID: 11736904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment of inflammatory facial dermatoses with topical corticosteroids: focus on clocortolone pivalate 0.1% cream.
    Kircik LH; Del Rosso JQ
    J Drugs Dermatol; 2012 Oct; 11(10):1194-8. PubMed ID: 23134984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel topical agent containing superoxide dismutase 100 000 IU and 4% of plant extracts as a mono-therapy for atopic dermatitis.
    Sgouros D; Katoulis A; Rigopoulos D
    J Cosmet Dermatol; 2018 Dec; 17(6):1069-1072. PubMed ID: 29134748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sun exposure is an aggravating factor responsible for the recalcitrant facial erythema in adult patients with atopic dermatitis.
    Deguchi H; Danno K; Sugiura H; Uehara M
    Dermatology; 2002; 204(1):23-8. PubMed ID: 11834845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A starch, glycyrretinic, zinc oxide and bisabolol based cream in the treatment of chronic mild-to-moderate atopic dermatitis in children: a three-center, assessor blinded trial.
    Licari A; Ruffinazzi G; DE Filippo M; Castagnoli R; Marseglia A; Agostinis F; Puviani M; Milani M; Marseglia GL
    Minerva Pediatr; 2017 Dec; 69(6):470-475. PubMed ID: 29181960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.
    Wahn U; Bos JD; Goodfield M; Caputo R; Papp K; Manjra A; Dobozy A; Paul C; Molloy S; Hultsch T; Graeber M; Cherill R; de Prost Y;
    Pediatrics; 2002 Jul; 110(1 Pt 1):e2. PubMed ID: 12093983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of whey associated with dodder seed extract on moderate-to-severe atopic dermatitis in adults: A randomized, double-blind, placebo-controlled clinical trial.
    Mehrbani M; Choopani R; Fekri A; Mehrabani M; Mosaddegh M; Mehrabani M
    J Ethnopharmacol; 2015 Aug; 172():325-32. PubMed ID: 26151244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathological features of recalcitrant erythema of the face in adult patients with atopic dermatitis.
    Omoto M; Sugiura H; Uehara M
    J Dermatol; 1994 Feb; 21(2):87-91. PubMed ID: 8182217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of head and neck dermatitis comparing itraconazole 200 mg and 400 mg daily for 1 week with placebo.
    Svejgaard El; Larsen PØ; Deleuran M; Ternowitz T; Roed-Petersen J; Nilsson J
    J Eur Acad Dermatol Venereol; 2004 Jul; 18(4):445-9. PubMed ID: 15196159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, vehicle-controlled, half-side comparison with a herbal ointment containing Mahonia aquifolium, Viola tricolor and Centella asiatica for the treatment of mild-to-moderate atopic dermatitis.
    Klövekorn W; Tepe A; Danesch U
    Int J Clin Pharmacol Ther; 2007 Nov; 45(11):583-91. PubMed ID: 18077922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in treatment adherence with a 3-day course of fluocinonide cream 0.1% for atopic dermatitis.
    Yentzer BA; Ade RA; Fountain JM; Clark AR; Taylor SL; Borgerding E; Feldman SR
    Cutis; 2010 Oct; 86(4):208-13. PubMed ID: 21140931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety, efficacy, and dosage of 1% pimecrolimus cream for the treatment of atopic dermatitis in daily practice.
    Lübbe J; Friedlander SF; Cribier B; Morren MA; García-Díez A; Gelmetti C; Hofmann H; Houwing RH; Kownacki S; Langley RG; Virtanen M; Wolff K; Wisseh S; McGeown C; Abrams B; Schneider D;
    Am J Clin Dermatol; 2006; 7(2):121-31. PubMed ID: 16605292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.